Our business strategy is to create value for our stakeholders by promoting access to medicines through building robust product portfolios that achieve organic growth and by leveraging our world-class manufacturing capacities and capabilities. We seek to achieve this by building a differentiated portfolio of relevant IP, creating value through our complex manufacturing capabilities and enabling access through our globally integrated supply chain.
Our market positioning is focused on opportunities presented by emerging markets, balanced with presence in more established, stable developed markets. Through our dynamic portfolio management model, we build, optimise and reshape our basket of products to achieve a global product portfolio of niche, specialty products complemented by leading regional brands, aligned to our manufacturing capability.
We have proven manufacturing capability and capacity, creating access and sustainability collaboration opportunities for multinationals.
| Firm | Analyst | Contact Details | |
|---|---|---|---|
|
Covering Analyst |
ABSA |
Rendani Magalela |
rendani.magalela@absa.africa |
|
Covering Analyst |
HSBC |
Raj Sinha |
raj.sinha@hsbc.com |
|
Covering Analyst |
JPM |
Alex Comer |
alex.r.comer@jpmorgan.com |
|
Covering Analyst |
Nedbank |
Luyanda Njilo |
luyandan@nedbank.co.za |
